Name | NAUCHNO-TEKHNOLOGICHESKIY TSENTR BIOINVEST, OOO |
---|
INN | 7727559027 |
---|
KPP | 772901001 |
---|
OGRN | 1057748973897 |
---|
OKPO | 79363533 |
---|
Address | 119234, G.moskva, ter Leninskie Gory, d. D. 1, of. ETAZH/KOM 1/101A |
---|
Phone | Contact details |
|
OKVED code | Type | Name of activity type |
---|
21.20 | Core activity | Manufacturers of drugs and pharmaceuticals and medical products | 21.10 | Additional activity | Manufacture of manmade fibres | 46.46.1 | Additional activity | Wholesale of furniture, carpets and lighting equipment | All types of activities | 71.20.9 | Additional activity | Activities for technical control, testing and other analysis | 72.19 | Additional activity | Research and experimental development on natural sciences and engineering Other | 73.20.1 | Additional activity | Market and opinion research |
Registration date | 08.11.2005 |
---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 46 po g. Moskve |
---|
|
NTTS BIOINVEST, OOO (Moscow; INN 7727559027) was registered on 8 Nov 2005. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of NTTS BIOINVEST, OOO - Limited liability companies. Form of ownership of NTTS BIOINVEST, OOO - Private property. Principal activities of NTTS BIOINVEST, OOO: manufacturers of drugs and pharmaceuticals and medical products (21.20), manufacture of manmade fibres (21.10), wholesale of furniture, carpets and lighting equipment (46.46.1). |
Economic indicators2023
Net profit (RAS) of NTTS BIOINVEST, OOO dropped in 2023 by 43.97% to 650.00 thousand RUB from 1.16 million RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 6.81% to 76.72 million RUB from 82.32 million RUB in 2022. 2022
Net profit (RAS) of NTTS BIOINVEST, OOO grew over 2022 4.51 times to 1.16 million RUB from 257.00 thousand RUB over 2021, the company informed. Revenue increased in the accounting period by 10.23% to 82.32 million RUB from 74.68 million RUB over 2021. 2021
Net profit (RAS) of NAUCHNO-TEKHNOLOGICHESKIY TSENTR BIOINVEST, OOO dropped in 2021 26.92 times to 256.00 thousand RUB from 6.89 million RUB over the same period in 2020, the company informed. Revenue increased in the accounting period by 15.26% to 74.68 million RUB from 64.80 million RUB over 2020. 2020
Net profit (RAS) of NTTS BIOINVEST, OOO grew over 2020 5.79 times to 6.89 million RUB from 1.19 million RUB over 2019, the company informed. Revenue increased in the accounting period by 15.33% to 64.80 million RUB from 56.18 million RUB over 2019; cost of goods sold grew by 4.11% to 32.53 million RUB from 31.25 million RUB; sales profit went up by 14.46% to 6.70 million RUB from 5.85 million RUB. 2019
Net profit (RAS) of NTTS BIOINVEST, OOO dropped in 2019 by 44.52% to 1.19 million RUB from 2.15 million RUB over the same period in 2018, the company informed. Revenue increased in the accounting period by 24.70% to 56.18 million RUB from 45.05 million RUB over 2018; cost of goods sold grew by 30.74% to 31.25 million RUB from 23.90 million RUB; sales profit fell by 25.90% to 5.85 million RUB from 7.90 million RUB. 2018
Net profit (RAS) of NTTS BIOINVEST, OOO grew over 2018 8.32 times to 2.15 million RUB from 258.00 thousand RUB over 2017, the company informed. Revenue increased in the accounting period 1.96 times to 45.05 million RUB from 23.00 million RUB over 2017; cost of goods sold grew 2.33 times to 23.90 million RUB from 10.26 million RUB; sales profit made up 7.90 million RUB compared to sales loss of 7.67 million RUB. 2017
Net profit (RAS) of NTTS BIOINVEST, OOO dropped in 2017 4.73 times to 258.00 thousand RUB from 1.22 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 18.48% to 23.00 million RUB from 28.22 million RUB in 2016; cost of goods sold grew 1.60 times to 10.26 million RUB from 6.39 million RUB; sales loss decreased by 38.53% to 7.67 million RUB from 12.47 million RUB. 2016
Net profit (RAS) of NTTS BIOINVEST, OOO made up 1.22 million RUB over 2016 compared to net loss of 12.90 million RUB over 2015, the company informed. Revenue increased in the accounting period 1.55 times to 28.22 million RUB from 18.19 million RUB over 2015; cost of goods sold grew 1.58 times to 6.39 million RUB from 4.04 million RUB; sales loss decreased by 45.20% to 12.47 million RUB from 22.75 million RUB. 2013
Net profit (RAS) of NTTS BioInvest, OOO made up 23.00 thousand RUB over 2013 compared to net loss of 462.00 thousand RUB over 2012, the company informed. Sales profit made up 37.00 thousand RUB compared to sales loss of 692.00 thousand RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|